CoChat

Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 27 of the 37 sources its claims cite were checked for support.

Abstract

BACKGROUND: Genetic studies reveal that single-nucleotide polymorphisms (SNPs) of SPI1 are associated with Alzheimer's disease (AD), while their effects in the Chinese population remain unclear. OBJECTIVE: We aimed to examine the AD-association of SPI1 SNPs in the Chinese population and investigate the underlying mechanisms of these SNPs in modulating AD risk. METHODS: We conducted a genetic analysis of three SPI1 SNPs (i.e., rs1057233, rs3740688, and rs78245530) in a Chinese cohort (n = 333 patients with AD, n = 721 normal controls). We also probed public European-descent AD cohorts and gene expression datasets to investigate the putative functions of those SNPs. RESULTS: We showed that SPI1 SNP rs3740688 is significantly associated with AD in the Chinese population (odds ratio [OR] = 0.72 [0.58-0.89]) and identified AD-protective SPI1 haplotypes β (tagged by rs1057233 and rs3740688) and γ (tagged by rs3740688 and rs78245530). Specifically, haplotypes β and γ are associated with decreased SPI1 gene expression level in the blood and brain tissues, respectively. The regulatory roles of these haplotypes are potentially mediated by changes in miRNA binding and the epigenetic landscape. Our results suggest that the AD-protective SPI1 haplotypes regulate pathways involved in immune and neuronal functions. CONCLUSION: This study is the first to report a significant association of SPI1 with AD in the Chinese population. It also identifies SPI1 haplotypes that are associated with SPI1 gene expression and decreased AD risk.

Overview

CoChat Summary

TL;DR

This study reports that SPI1 SNP rs3740688 and haplotypes β and γ are associated with reduced Alzheimer’s disease (AD) risk in a Hong Kong Chinese cohort, with haplotype γ also showing protective effects in APOE ε3 homozygous European-descent cohorts. The protective haplotypes are linked to decreased SPI1 expression in blood or brain and to immune/neuronal pathways.

Key findings

  • In the Chinese cohort (333 AD, 721 controls), rs3740688 was significantly AD-protective (OR = 0.72 [0.58–0.89]; adjusted Beta = –0.326±0.109, p = 0.003; APOE-adjusted Beta = –0.350±0.113, p = 0.002).
  • Haplotypes β (rs1057233–rs3740688) and γ (rs3740688–rs78245530) were AD-protective in Chinese participants (β: Beta = –0.337±0.118, p = 0.004; γ: Beta = –0.726±0.342, p = 0.034), with β remaining significant after APOE adjustment (Beta = –0.368±0.122, p = 0.003).
  • In European-descent APOE33 participants, haplotype γ was AD-protective (Beta = –0.213±0.137, p = 0.030), and meta-analysis across Chinese and European APOE33 participants gave Beta = –0.248±0.133, p = 0.015, though this did not pass the multiple-testing threshold (0.05/6 = 0.0083).
  • Haplotype γ was associated with delayed AD onset (HR = 0.54 [0.30–0.95], p = 0.035) and better MMSE performance (Beta = 0.173±0.066, p = 0.009) in APOE33 European-descent cohorts; it was also associated with decreased SPI1 expression in cortex (Beta = –0.447±0.166, p = 0.008) and frontal cortex (Beta = –0.361±0.174, p = 0.039), while haplotype β was associated with decreased SPI1 expression in blood (Beta = –0.119±0.060, p = 0.047) and strongly in monocytes/macrophages (p < 2×10–9).

Methods

  • Genetic association analysis of three SPI1 SNPs (rs1057233, rs3740688, rs78245530) in a Hong Kong Chinese AD cohort (n = 333 AD, n = 721 normal controls), using TaqMan genotyping and whole-genome sequencing data.
  • Replication and endophenotype analyses used European-descent AD cohorts (ADNI, ADC, LOAD; n = 5,094 AD, n = 4,663 controls) and expression datasets (GTEx, BRAINEAC, Cardiogenics), with haplotype-based logistic regression adjusted for age, sex, APOE, and principal components where applicable.
  • Meta-analysis used METASOFT with random-effects and RE2 models; downstream analyses included Gene Ontology, protein–protein interaction networks, miRNA-binding prediction, and epigenetic annotation of SPI1 regulatory regions.

Limitations

  • The paper states that larger cohorts and additional independent cohorts are needed to confirm the SPI1 haplotype–AD associations and their effects on age of onset and cognition, and that functional studies are needed to elucidate how haplotypes modulate SPI1 expression and microglial AD-associated functions.
  • Evident from the text: the European-descent haplotype γ AD-protective effect was observed only in APOE33 participants, and the cross-population meta-analysis did not pass the multiple-testing correction threshold.
  • Evident from the text: some key findings rely on public datasets and in silico/epigenetic annotations, and the homozygous haplotype γ carrier analysis in LOAD involved only n = 10 individuals.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3233/jad-215311

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Identification of Alzheimer’s disease-protective SPI1 haplotypes. a) Linkage disequilibrium plot and haplotypes identified in the Hong Kong Chinese Alzheimer’s disease (AD) cohort. Cell color and labeled numbers in the upper and lower panels represent D’ and Pearson’s correlation coefficients (r2) between single-nucleotide polymorphisms (SNPs), respectively. Letters in upper and lower case denote major and minor alleles, respectively. b) AD-protective effects of the identified haplotypes in populations of Chinese and European descent. Dot size and filled color represent – log10(P) and Beta, respectively. **p < 0.01, *p < 0.05. c) Associations between haplotype γ and age of AD onset in APOE33 participants from the Late Onset Alzheimer’s Disease (LOAD) cohort. d) Associations between haplotype γ and Mini–Mental State Examination (MMSE) score in APOE33 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. **p < 0.01. CHN, Chinese; EUR, European descent; HR, hazard ratio.
Fig. 1 Identification of Alzheimer’s disease-protective SPI1 haplotypes. a) Linkage disequilibrium plot and haplotypes identified in the Hong Kong Chinese Alzheimer’s disease (AD) cohort. Cell color and labeled numbers in the upper and lower panels represent D’ and Pearson’s correlation coefficients (r2) between single-nucleotide polymorphisms (SNPs), respectively. Letters in upper and lower case denote major and minor alleles, respectively. b) AD-protective effects of the identified haplotypes in populations of Chinese and European descent. Dot size and filled color represent – log10(P) and Beta, respectively. **p < 0.01, *p < 0.05. c) Associations between haplotype γ and age of AD onset in APOE33 participants from the Late Onset Alzheimer’s Disease (LOAD) cohort. d) Associations between haplotype γ and Mini–Mental State Examination (MMSE) score in APOE33 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. **p < 0.01. CHN, Chinese; EUR, European descent; HR, hazard ratio.CC BY-NC · PubMed Central
Fig. 2 Effects of SPI1 haplotypes on the regulation of SPI1 transcript level. a–c) Associations between SPI1 haplotypes and SPI1 transcript level in (a) the cortex, (b) monocytes, and (c) macrophages from APOE33 donors. Rectangles and error bars denote the effect size and standard error, respectively. ***p < 0.001, **p < 0.01, *p < 0.05. d) Epigenetic modification of the SNP-harboring region for the SPI1 haplotypes’ tag SNPs. Panels from top to bottom are the gene structure and coordinates of SPI1. Boxes and lines denote exons and introns, respectively. Red and yellow bars represent candidate cis-regulatory elements (ccREs) with high H3K4me3 and H3K27ac signals, respectively. Signals of DNase sequencing (DNase-seq), H3K4me3 chromatin immunoprecipitation sequencing (ChIP-seq), and H3K27ac ChIP-seq in the cerebral cortex. Signals of single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) in the cerebral cortex. Signals of DNase-seq, H3K4me3 ChIP-seq, and H3K27ac ChIP-seq in blood mononuclear cells. Please refer to Supplementary Figure 2 for all available biological replicates. Astro, astrocyte. ExN, excitatory neuron; InN, Inhibitory neuron; Micro, microglia; Oligo, oligodendrocyte; OPC, oligodendrocyte progenitor cell.
Fig. 2 Effects of SPI1 haplotypes on the regulation of SPI1 transcript level. a–c) Associations between SPI1 haplotypes and SPI1 transcript level in (a) the cortex, (b) monocytes, and (c) macrophages from APOE33 donors. Rectangles and error bars denote the effect size and standard error, respectively. ***p < 0.001, **p < 0.01, *p < 0.05. d) Epigenetic modification of the SNP-harboring region for the SPI1 haplotypes’ tag SNPs. Panels from top to bottom are the gene structure and coordinates of SPI1. Boxes and lines denote exons and introns, respectively. Red and yellow bars represent candidate cis-regulatory elements (ccREs) with high H3K4me3 and H3K27ac signals, respectively. Signals of DNase sequencing (DNase-seq), H3K4me3 chromatin immunoprecipitation sequencing (ChIP-seq), and H3K27ac ChIP-seq in the cerebral cortex. Signals of single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) in the cerebral cortex. Signals of DNase-seq, H3K4me3 ChIP-seq, and H3K27ac ChIP-seq in blood mononuclear cells. Please refer to Supplementary Figure 2 for all available biological replicates. Astro, astrocyte. ExN, excitatory neuron; InN, Inhibitory neuron; Micro, microglia; Oligo, oligodendrocyte; OPC, oligodendrocyte progenitor cell.CC BY-NC · PubMed Central
Fig. 3 Associations between haplotype γ and transcriptomic changes in the cerebral cortex in APOE33 donors. a) Volcano plot showing the associations between haplotype γ and cortical gene expression. b) Gene Ontology analysis of genes modulated by haplotype γ in the cerebral cortex. c) Protein–protein interaction network of genes involved in immune and neuronal functions. Nodes and edges denote genes and their interactions. Node shapes represent the ontology of corresponding genes. Node colors denote the effect size of haplotype γ on transcript level.
Fig. 3 Associations between haplotype γ and transcriptomic changes in the cerebral cortex in APOE33 donors. a) Volcano plot showing the associations between haplotype γ and cortical gene expression. b) Gene Ontology analysis of genes modulated by haplotype γ in the cerebral cortex. c) Protein–protein interaction network of genes involved in immune and neuronal functions. Nodes and edges denote genes and their interactions. Node shapes represent the ontology of corresponding genes. Node colors denote the effect size of haplotype γ on transcript level.CC BY-NC · PubMed Central

Verification

Claims the paper makes

16 Valid · 3 Not valid · 9 Not checked · 71 Own results and interpretations

56 more claims · 4 with their cited sources checked

Create a free account to see all 99 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 22
  • Probably not a substantial claim. 16
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 29

Metadata

Authors
Cao, H., Initiative, A. D. N., Zhou, X., Chen, Y., Ip, F. C. F., Chen, Y., Lai, N. C. H., Lo, R. M. N., Tong, E. P. S., Mok, V. C. T., Kwok, T. C. Y., Fu, A. K. Y., & Ip, N. Y.
Affiliations
  • Hong Kong University of Science and Technology (HK)
  • Chinese Academy of Sciences (CN)
  • Chinese University of Hong Kong (HK)
Corresponding author
Ip, Nancy Y.
Venue
Journal of Alzheimer s Disease
Published
2022-04-19
Volume
86
Issue
4
Pages
1861-1873
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W4214632026
Cited by
29
References
53
Citations by year
2026: 4 · 2025: 11 · 2024: 7 · 2023: 6 · 2022: 1
FWCI
2.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
Funders
  • Alzheimer's Disease Neuroimaging Initiative
  • National Natural Science Foundation of China (32061160472, 2018B030336001, 2019003, 2018YFE0203600, 2019B1515130004, 2019001)
  • University Grants Committee (T13-607/12R, AoE/M-604/16)
  • Innovation and Technology Commission (ITC PD/17-9)
  • Shenzhen Knowledge Innovation Program (JCYJ20180507183642005)
  • National Institute on Aging
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
PU.1, Alzheimer's disease
MeSH terms
Proto-Oncogene Protein Spi-1, Alzheimer Disease, China, Haplotypes, Humans, Proto-Oncogene Proteins, Trans-Activators, Gene Expression, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.